The FDA defines a protein as an alpha amino acid polymer with a specific defined sequence that is greater than 40 amino acids in size. It reads like a formality. It is not. That one sentence decides which of two entirely separate regulatory frameworks applies to a molecule, and for compounds sitting near the threshold, the decision can come down to how two residues are counted.
Two words carry the whole rule
Alpha. Amino acids are named for where the amino group attaches relative to the carboxyl carbon. In an alpha amino acid it sits on the immediately adjacent carbon. All twenty of the residues biology builds proteins from are alpha amino acids, so in a naturally occurring sequence the distinction rarely comes up. In synthetic chemistry it comes up constantly, because synthesis is not limited to what biology uses.
Size. A chain has a length. A molecule has a total composition. Those are not the same number. Synthetic peptides routinely carry components attached to the chain that are not part of the chain, and whether those get counted is a question the wording has to answer.
Why non-canonical residues show up in research peptides
Chemists modify peptide backbones for reasons that have nothing to do with regulation. The most common target is stability in solution, because an unmodified peptide sequence is a substrate for peptidases and gets cleaved quickly.
Two modifications appear often enough to be worth naming.
Aib, alpha-aminoisobutyric acid, is a residue carrying an extra methyl group on the alpha carbon. Substituting it into a sequence restricts the backbone’s freedom to rotate and blocks the cleavage sites that peptidases recognize. It also pushes the local structure toward a helix. It appears across a large fraction of modern synthetic peptide research for exactly these reasons.
Alpha-methyl-leucine does a similar job through the same mechanism, adding a methyl group at the alpha position of a leucine residue to hinder enzymatic attack at that point in the chain.
Both are alpha amino acids. Both are non-canonical, meaning they are not among the twenty the genetic code specifies. That combination is the source of most of the counting difficulty, because “not one of the standard twenty” and “not an alpha amino acid” are different objections and get conflated.
Lipid conjugation is a separate question again
Many research peptides carry a fatty acid or fatty diacid attached to a lysine side chain. This is a conjugation, not a chain extension. The attached group changes how the molecule behaves in solution and how it associates with albumin, which is why it is used.
For counting purposes it raises a structural question with no obvious answer from the wording alone. The conjugate is covalently bonded. It is unambiguously part of the molecule. It is just as unambiguously not part of the amino acid sequence. A rule that counts “amino acids in size” has to decide which of those two facts governs.
A worked example
Retatrutide is a useful structure to walk through because it sits close enough to the threshold that each of the distinctions above matters.
The published structure is a 39-residue synthetic peptide. The sequence incorporates non-canonical alpha-aminoisobutyric acid residues and an alpha-methyl-leucine residue. It terminates in a C-terminal serinamide rather than a free carboxyl group. It carries a lysine-conjugated fatty diacid moiety.
Count the backbone and the number is 39, below the threshold. Count the backbone plus the additional bonded amino acid components and the number reaches 41, above it. Both counts describe the same molecule accurately. They answer different questions.
What a researcher takes from this
The practical point is not the regulatory outcome. It is that a specification sheet’s residue count is an answer to a specific question, and the question is not always stated. A sequence length, a total amino acid component count, and a molecular weight are three different measurements, and a document reporting one of them is not reporting the others.
The same care applies when reading analytical documentation. A purity figure by reversed-phase HPLC describes the proportion of peptide-related material eluting as the main peak. It is not an identity confirmation, it is not a net peptide content measurement, and it does not speak to what fraction of the vial’s mass is water or counterion. Those are separate tests answering separate questions, and a report showing one does not imply the others.
Frequently asked questions
What counts as an alpha amino acid?
One where the amino group sits on the carbon immediately adjacent to the carboxyl group. This includes many residues outside the standard twenty, so non-canonical and non-alpha are not the same category.
Why would a sequence contain Aib?
To restrict backbone rotation and block peptidase cleavage at that position, which extends how long the molecule survives in solution. It is a stability modification.
Does a lipid conjugate change the amino acid count?
The conjugate is not an amino acid, so it does not extend the sequence. Whether it affects a molecule’s measured size depends entirely on which measurement is being reported.
Is molecular weight the same as residue count?
No. Molecular weight includes all atoms in the molecule, conjugates and modifications included. Residue count describes the chain alone. A compound can be unremarkable on one measure and notable on the other.
Etched Research supplies lyophilized research compounds for laboratory use. Where an independent laboratory report exists for a compound, the measurements are published on the COA page, including the compounds we hold no report for. More compound background is in the research library, and the full catalog is at the shop.
For research use only. Not for human or veterinary use.
For Research Use Only. Not for human consumption. Etched Research supplies compounds for laboratory and research use only. Nothing on this page is medical advice, a health claim, or a recommendation to use.